Reb Tayyabkhan is the Head of Central Clinical Services at Bristol Myers Squibb. He is responsible for Vendor and Outsourcing Management, R&D Contracts and Transparency across as phases of development.

He is a member of TransCelerate as the sponsor for the risk based monitoring initiative as well as the liaison to the CRO Forum. Prior to joining BMS, Reb worked at PwC and Merck.

Reb has a BA (Chemistry) and MBA from NYU and a MEng (Chemical) from Cornell.